bioMérieux

SpinChip Diagnostics AS, founded in 2012 and based in Oslo, Norway, specializes in developing point-of-care systems utilizing lab-on-a-chip technology for diagnosing various health conditions, including cardiovascular, endocrine, anemic, diabetic, infectious, and inflammatory diseases. The company is focused on providing a state-of-the-art platform for in vitro diagnostics that enables rapid, reliable analyses of blood samples in both hospital and decentralized medical settings. This fully automated device delivers results within minutes, initially targeting the rapid cardiac segment with a Troponin-I analysis currently under development. SpinChip aims to expand its offerings to include a comprehensive cardiac panel, ensuring that its platform matches the quality of high-sensitivity central laboratory analyzers, thus presenting a compelling value proposition compared to existing point-of-care solutions.

Oxford Nanopore Technologies is a biotechnology company specializing in nanopore-based sequencing technology for analyzing DNA, RNA, proteins, and small molecules. Its diverse product line includes the portable MinION device, the benchtop PromethION, the GridION system, and Flongle, which caters to on-demand sequencing needs. The technology enables real-time data streaming and is applicable across various fields such as human genomics, cancer research, microbiology, plant science, and environmental studies. Additionally, Oxford Nanopore's products support rapid and accessible molecular analysis, making them suitable for both laboratory and field use. The company's innovations are backed by a robust patent portfolio and are utilized in over 80 countries, addressing needs in healthcare, agriculture, and education. Founded in 2005 and headquartered in Oxford, United Kingdom, Oxford Nanopore also maintains offices in several other countries, enhancing its global reach in advancing genomic research and applications.

Proxim Diagnostics Corp. specializes in the development and manufacturing of handheld immuno diagnostic devices that facilitate immediate laboratory testing near patients. Founded in 2009 and based in Mountain View, California, the company offers handheld analyzers and disposable test cartridges that can assess blood gases, electrolytes, metabolites, and infectious disease antigens and antibodies. These devices are designed for use in various medical environments, including emergency medical services, emergency rooms, intensive care units, nursing facilities, and rural clinics. By utilizing whole blood samples without compromising sensitivity or precision, Proxim Diagnostics ensures rapid test results, which are crucial for timely patient care. The company aims to provide a unique blend of high performance and cost-effectiveness, making its products suitable for both domestic and international healthcare settings.

InDevR, Inc. is a biotechnology company based in Boulder, Colorado, focused on developing and marketing life science instrumentation and assay products for the analysis of viruses and microorganisms. The company offers a range of products including the Virus Counter for virus quantification, the FluChip for rapid pathogen detection, and the ViroPrep Allantoic Influenza kit for sample preparation. Additionally, InDevR provides the miPLEX platform for multiplexed immunoassays, the Vidia fluorescence microarray imaging system, and the ampliPHOX Reader for image interpretation of microarrays. These innovative technologies support vaccine research, development, and manufacturing by facilitating the tracking of seasonal and emerging influenza viruses, as well as enhancing diagnostic applications in the life sciences industry. InDevR was incorporated in 2002.

Accunome is a company specializing in molecular diagnostic technology, focusing on the development of diagnostic instruments and detection reagents. It emphasizes research and development to enhance diagnostic efficiency and reduce costs for clients in the healthcare sector. Accunome has received state food and drug registration and EU CE certifications for its diagnostic platform, DXcellence12, as well as for its combined detection kit for influenza A/B and respiratory syncytial virus nucleic acid. Through its innovative solutions, the company aims to facilitate the diagnosis of severe infectious diseases.

Specific Diagnostics, LLC is a medical device company based in West Palm Beach, Florida, founded in 2011. The company specializes in developing solutions for the detection, identification, and antibiotic susceptibility testing of pathogens. Its flagship product, the Specific Reveal system, utilizes patented technology that incorporates a low-cost small molecule sensor. This system is designed to streamline workflows in clinical settings and accelerate the time required to obtain diagnostic results, ultimately enhancing patient care by providing timely and specific treatment options.

Accellix, Inc. is a biotechnology company focused on developing microflow cytometer systems for diagnostic applications. The company specializes in compact, tabletop flow cytometry instruments that utilize microfluidics technology, along with disposable, test-specific cartridges designed for use with these portable devices. Accellix's products provide diagnostic information for early detection of blood infections and are applicable in areas such as sepsis detection and HIV/AIDS monitoring. The company's innovations help cell and gene therapy organizations fulfill quality control requirements by offering multi-parameter results through room temperature stable cartridges. Founded in 2009 and headquartered in San Jose, California, with an additional office in Jerusalem, Accellix serves the point-of-care testing and flow cytometry markets, aiming to improve patient outcomes through accurate and efficient diagnostic solutions.

Invisible Sentinel Inc. specializes in microbial detection tools tailored for food safety, environmental testing, healthcare, and various industries such as wine and beer production. Founded in 2006 and based in Philadelphia, Pennsylvania, the company offers a range of test kits, including Veriflow, which identifies common food pathogens and spoilage organisms like salmonella and E. coli. Their vinoBRETT kits cater to winemakers by detecting spoilage organisms, while brewPAL kits provide same-day analysis for brewers. Invisible Sentinel's innovative technologies are designed for practical on-site use throughout the food distribution network, facilitating rapid and accurate diagnostics that enhance quality control. As of early 2019, the company operates as a subsidiary of bioMérieux S.A.

SuZhou Hybiome Biomedical Engineering Co., Ltd. specializes in the research, manufacturing, and sale of diagnostic instruments and reagents for clinical immunological analysis and blood testing. Established in 2009 and based in Suzhou, China, the company offers a range of products, including automatic luminescence immunoassay analyzers paired with corresponding reagents, as well as automatic blood grouping analyzers designed for micro-column gel immunoassay techniques. These solutions are aimed at enhancing the reliability, efficiency, and accuracy of medical diagnoses, thereby supporting healthcare providers in delivering quality patient care. As of November 2018, SuZhou Hybiome operates as a subsidiary of bioMérieux S.A.

Astute Medical, Inc. is a life science tools company specializing in the discovery and development of protein biomarkers for rapid diagnosis and risk assessment of acute medical conditions. Founded in 2007 and based in San Diego, California, with a location in Paris, France, the company focuses on validating prognostic biomarkers related to conditions such as abdominal pain, acute coronary syndromes, cerebrovascular injury, kidney injury, and sepsis. Its primary product, NephroCheck, is a single-use cartridge designed to detect biomarkers of acute kidney injury, while the Astute140 meter converts the fluorescent signals from the NephroCheck cartridge into a single numerical result. Astute Medical's products are marketed in the United States and Europe and aim to enhance clinical decision-making and patient outcomes. As of April 2018, Astute Medical operates as a subsidiary of bioMérieux S.A.

Qvella Corporation is a Toronto-based molecular diagnostics company founded in 2009 by a group of scientists and engineers. The company focuses on transforming clinical microbiology by significantly reducing the time required to obtain results for bloodstream infections. Qvella's innovative Field Activated Sample Treatment (FAST™) technology employs a novel electrical lysing technique, known as e-lysis™, which facilitates the rapid and fully automated detection of infectious agents directly from unenriched biological samples. This capability allows clinicians to identify microorganisms in infected whole blood samples without the lengthy sample processing typically required, ultimately enhancing patient outcomes and saving lives.

Hyglos GmbH is a biotech company based in Bernried am Starnberger See, Germany, founded in 2000 and formerly known as Profos AG. The company specializes in the development of bacteriophage-derived proteins that enhance the detection and removal of harmful bacteria and their toxins, particularly Lipopolysaccharides (LPS). Hyglos utilizes principles from bacteriophage biology to create diagnostic and antimicrobial solutions, addressing challenges in endotoxin detection, demasking, and removal, as well as providing endotoxin-free products. Its product offerings include various detection kits, demasking kits, and reagents, tailored for applications in food safety testing, human diagnostics, and research. The company serves a diverse clientele, including universities, research institutes, diagnostic and biotech companies, and food safety laboratories, distributing its products globally through distributors. As of 2016, Hyglos operates as a subsidiary of bioMérieux S.A.

Applied Maths specializes in creating professional bioinformatics applications and services tailored for the biosciences sector. The company focuses on developing software products that facilitate the databasing, analysis, and interpretation of complex biological data. With an emphasis on data integration and platform technology, Applied Maths aims to enhance the efficiency and effectiveness of data management and analysis in the life sciences field.

SARL ADVENCIS is a privately held company that manufactures lab instruments and medical devices.

BioFire Diagnostics is a clinical diagnostics company based in Salt Lake City, Utah, that focuses on detecting pathogens and mutations for molecular diagnostics. Founded in 1990, the company holds over 70 patents related to polymerase chain reaction (PCR) technology, including innovations in rapid PCR cycling. BioFire offers nearly 200 products tailored for clinical, research, and military applications. Its services are designed to provide accurate results in syndromic infectious disease diagnostics, utilizing real-time thermocycling and mutation scanning. BioFire's diagnostic panels test for a wide range of viruses, bacteria, and antimicrobial resistance genes, thereby enabling healthcare providers to assess and improve treatment outcomes for patients of all ages.

Quanterix Corporation is a life sciences company focused on developing an ultra-sensitive digital immunoassay platform to advance precision health in diagnostics and research. Their proprietary technology, Simoa, enables the detection of protein biomarkers at very low concentrations in biological samples such as blood and serum, which are often undetectable using traditional methods. This high level of sensitivity allows for earlier disease detection, improved prognosis, and more precise treatment methods. Quanterix's platforms include bead-based and planar array systems designed to provide reliable and robust assay performance, addressing various unmet medical needs in clinical diagnostics, drug development, and life science research.

RTS Life Sciences Ltd. manufactures and provides automated products and solutions for industrial and scientific applications.

RAS Lifesciences is a manufacturer of diagnostic kits located in Muluga, India. The company specializes in the development and production of molecular biology-based products, aiming to advance diagnostic solutions in the healthcare sector. Through its focus on innovative technologies, RAS Lifesciences contributes to the field of diagnostics by providing tools that enhance the accuracy and efficiency of medical testing.

Argene SA is a specialising in molecular diagnostics for immunocompromised patients.

AES Laboratoire has products spanning applications for the food, pharmaceutical, and cosmetic industries. The company’s offerings include a complete portfolio of conventional and novel culture media, rapid microbiology testing methods, and laboratory instruments, as well as cytometry for the detection of microorganisms, with an innovative range of flow cytometers and a solid-phase cytometer, ChemScan RDI. The company also provides a range of services, as well as software for laboratory monitoring and metrology.

Shanghai Zenka Biotechnology is a biotechnology company.

Meikang Biotech is a manufacturer of medical rapid test products that utilize lateral flow immunoassay technology. The company provides a diverse array of tests that detect infectious diseases, cardiovascular conditions, and cancer. Many of its products have received CE marking, and several have achieved FDA 510(k) approval, underscoring their compliance with regulatory standards and effectiveness in clinical settings.

PML Microbiologicals, Inc. specializes in the manufacture of culture media and microbiological products tailored for clinical and industrial applications across North America. The company's extensive product offerings include prepared culture media, stains, reagents, quality control organisms, sterility products, and collection and transport systems, as well as laboratory accessories. Additionally, PML provides customized solutions such as minimum inhibitory concentration panels, parasitology kits, diluents, and rinsing fluids. The company serves a diverse range of sectors, including clinical, pharmaceutical, research, environmental, personal care, and food and beverage industries. Founded in 1969 and headquartered in Wilsonville, Oregon, PML Microbiologicals operates manufacturing facilities in Mississauga, Canada, and Portland, Oregon. It functions as a subsidiary of BioMérieux S.A.

AviaraDx discovers, develops, and commercializes new molecular diagnostic tests in oncology, enabling physicians to personalize cancer treatment through better understanding of the molecular biology underlying a patient’s tumor. Our tests improve the classification of cancer, support physicians to provide their patients with a more specific prognosis or individual risk assessment, and will eventually provide information critical to predict treatment response to a given therapeutic regimen. AviaraDx offers diagnostic tests to qualified physicians or laboratories through its certified CLIA and CAP laboratory service operations. The company's first two diagnostic test offerings are based on its proprietary technologies used in molecular classification of metastatic cancer (CancerTYPE ID™) and its test to assess risk of recurrence in certain breast cancer patients, (H/I™ (HOXB13/IL17BR).

AB bioMérieux is a privately held company that designs, develops, produces, and markets diagnosis systems for medical applications.

AdvanDx, Inc. is a biotechnology company based in Woburn, Massachusetts, specializing in molecular diagnostic tests aimed at identifying pathogens responsible for critical infections in hospitalized patients. Founded in 2002, the company develops rapid and accurate testing methods that allow clinical microbiology laboratories to report pathogen identification results significantly faster than traditional techniques. AdvanDx offers a range of products, including QuickFISH and PNA FISH tests for detecting bacteria and yeast from positive blood cultures, as well as XpressFISH for identifying resistance markers. Additionally, the company provides a variety of accessories and components to support its testing systems. Its products are distributed through a network in the Americas, Asia Pacific, Europe, the Middle East, and Africa, serving medical centers, reference laboratories, government institutions, and community hospitals. AdvanDx operates as a subsidiary of OpGen, Inc. since 2015.

BTF Pty is a manufacturer and supplier specializing in precise quality controls for Cryptosporidium and Giardia testing, essential for ensuring safe drinking water. The company also produces quantitative biological reference materials and standards tailored for the life sciences sector. These reference samples are utilized by analytical laboratories to enhance the quality control processes of their testing, thereby supporting public health and safety.

Biomedics is a specialized technical laboratory in elaboration of prepared culture and diagnostic media.

Bacterial Barcodes provides the equipment, reagents and software for microbial genotyping of bacteria and fungi. Packaged together, these components are referred to as the DiversiLab System.

Since 2017, MEDoctor's mission is to empower the patient to help himself determine his health problems and thereby to be routed towards the appropriate healthcare professional. The MEDoctor artificial intelligence based health assessment system won’t replace a medical visit to the doctor to have the final diagnosis and the correct treatment. But it will be useful to identify which pain, disease or illness can correspond to the symptoms you have and then make the choice of the physician to see or the treatment to follow. The MEDoctor Symptom Checker is a guide that will help you for all kinds of problems, for a benign disease as a cold or something more serious as a cancer. MEDoctor is one of the world’s most advanced symptom checkers, with its artificial intelligence and the patents to protect it. Diseases we can detect include back pain, knee pain, breast cancer, diabetes, skin cancer, heart disease, liver disease, depression, body aches, diarrhea, kidney infection, asthma, lymphoma. The list of possible disease covered is now close to 1'000. The MEDoctor Symptom Checker Version 4.1 is available “Free-of-Cost” to individuals worldwide. Individuals, family members and friends may use it as often as necessary and wherever the Internet is accessible. The system is user-friendly and works on any web-enabled device. Prior to 2017, MEDoctor had worked on and developed patient enrollment systems, such as registration at the HMO, delivery of basic health symptoms and populating of electronic health records. These systems, essentially mainframe computer based, were targeting hospitals, HMOs and IPAs and with the assistance of a healthcare professional. Since 2014, MEDoctor has taken a different route by progressively building upon its legacy systems a brand new technology, capable of running on the Cloud and suited for the patient on his smartphone. Thereafter, when the patient decides to speak to a physician, he can immediately deliver his accumulated data, symptoms and likely diseases, to facilitate the physicians diagnosis.